Position in PRTA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,192,676
-$51,866 QoQ
Shares Held
223,971
-3.0% QoQ
Ownership
0.436%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#35
of 187 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in PRTA Over Time
Shares Held
Position Value (USD)
Derivatives in PRTA
reported options exposure · as of Dec 31, 2024CallValue
$336,555
CallShares
24,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names. PRTA ranks #72 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
290,713 | $38,586,336 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in PRTA
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,192,676 | 223,971 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,244,542 | 230,920 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,082,291 | 218,041 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,239,842 | 127,033 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,270,141 | 209,249 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $336,555 | 24,300 | Call | Defined | 2025-02-14 | |
| 2023-12-31 | $2,690,250 | 74,030 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,560,356 | 32,339 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $3,795,637 | 78,309 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $332,339 | 5,516 | Shares | Defined | 2023-02-14 | |
| 2021-12-31 | $326,336 | 6,606 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $1,330,799 | 25,886 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $357,608 | 14,236 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $213,765 | 17,799 | Shares | Defined | 2021-02-16 | |
| 2020-06-30 | $157,569 | 15,064 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $299,846 | 28,023 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||